cardiovascular syphilis

cardiovascular syphilis is a late-stage complication of infection by the spirochete bacterium Treponema pallidum, the causative agent of syphilis. It represents a tertiary form of the disease, typically manifesting decades after the initial infection, and primarily involves the aorta and its proximal branches. The condition is characterized by an inflammatory process known as syphilitic aortitis, which can lead to life-threatening structural damage including aortic aneurysm, aortic regurgitation, and coronary ostial stenosis. Once a common cause of cardiovascular death, its incidence has dramatically declined in the post-World War II era with the widespread use of penicillin, though it remains a concern in regions with inadequate healthcare access.

Pathophysiology

The pathogenesis begins with the hematogenous dissemination of Treponema pallidum during early syphilis, with the organisms showing a tropism for the vasa vasorum of the aorta. This leads to a chronic obliterative endarteritis of these small vessels, impairing blood supply to the aortic media and initiating an inflammatory response. Over time, this causes necrosis of elastic fibers and smooth muscle cells within the tunica media, a process described as medial necrosis. The subsequent scarring and weakening of the aortic wall predisposes to dilation, aneurysm formation, and valvular incompetence. The most common site of involvement is the ascending aorta, particularly the aortic root, with the inflammatory process often extending to the aortic valve and the coronary ostia.

Clinical manifestations

Symptoms typically arise 10 to 30 years after the initial infection and are dictated by the specific cardiovascular structures involved. The classic presentation of uncomplicated syphilitic aortitis may be asymptomatic or cause nonspecific chest pain. The development of a syphilitic aneurysm of the ascending aorta can lead to a palpable pulsating mass, tracheal tug, or compressive symptoms like dysphagia and hoarseness due to pressure on the recurrent laryngeal nerve. Aortic valve involvement results in aortic regurgitation, presenting with signs such as the Corrigan's pulse, Austin Flint murmur, and symptoms of congestive heart failure. Stenosis of the coronary ostia can cause angina pectoris or myocardial infarction, even in the absence of traditional atherosclerosis.

Diagnosis

Diagnosis relies on a combination of clinical suspicion, serological testing, and advanced imaging. Serologic confirmation is essential, utilizing both nontreponemal tests like the Venereal Disease Research Laboratory (VDRL) or Rapid Plasma Reagin (RPR) and treponemal tests such as the Treponema pallidum particle agglutination (TPPA) or Fluorescent treponemal antibody absorption (FTA-ABS) test. Imaging is critical for defining anatomical damage; chest radiography may reveal a widened mediastinum or calcification of the ascending aorta. Computed tomography angiography (CTA) and magnetic resonance angiography (MRA) provide detailed assessment of aortic dilation, aneurysm, and dissection. Echocardiography, particularly transesophageal echocardiography (TEE), is invaluable for evaluating aortic root dimensions and the severity of aortic regurgitation.

Treatment and management

The cornerstone of treatment is antibiotic therapy with penicillin G, administered as either intravenous or intramuscular regimens depending on disease severity, following guidelines from organizations like the Centers for Disease Control and Prevention (CDC). Corticosteroids may be co-administered initially to mitigate a potential Jarisch-Herxheimer reaction. However, antibiotics cannot reverse established structural damage. Management of complications often requires surgical intervention, such as aortic valve replacement and graft repair of aneurysms, procedures historically pioneered by surgeons like Michael E. DeBakey. Collaboration between specialists in infectious disease, cardiology, and cardiothoracic surgery is paramount for optimal patient care.

Prognosis and complications

The prognosis is heavily dependent on the extent of cardiovascular damage at the time of diagnosis and treatment. Untreated, the condition is progressive and often fatal, with causes of death including ruptured aortic aneurysm, severe congestive heart failure, or complications from coronary artery involvement. Even with adequate penicillin therapy, patients remain at risk for the progression of aortic dilation and valvular dysfunction, necessitating lifelong surveillance with serial imaging. Major complications include aortic dissection, cardiac tamponade, and secondary infective endocarditis on damaged valves. The historical mortality was stark, as noted in studies from the pre-antibiotic era at institutions like Johns Hopkins Hospital.

Epidemiology

Once a leading cause of cardiovascular mortality, particularly among middle-aged men, the incidence of cardiovascular syphilis plummeted in developed nations following the introduction of penicillin after World War II and robust public health initiatives like the Tuskegee Study's aftermath highlighting ethical failures. It is now considered rare in countries with strong public health systems, such as the United States and members of the European Union. However, it persists as a clinical entity in regions with high syphilis prevalence and limited healthcare access, including parts of Sub-Saharan Africa and Asia. Resurgences in primary and secondary syphilis in cities like San Francisco and London underscore the potential for future tertiary cases, monitored by agencies including the World Health Organization (WHO).